Immunity to and Prevention of Herpes Zoster
Springer Verlag GmbH
978-3-211-83556-2 (ISBN)
- Keine Verlagsinformationen verfügbar
- Artikel merken
Varicella-zoster virus (VZV) causes both chickenpox and zoster. Fundamental to their prevention is an understanding of the natural history of VZV infection. This is a compilation of papers presented in March 1999 in Osaka, Japan, by internationally renowned researchers studying varicella-zoster virus and a vaccine used to prevent disease caused by this virus. The aim of the meeting was to explore progress made in basic and molecular biology of VZV and current understanding of latent infection and reactivation. Data concerning immune responses to VZV, mechanisms by which virus latency are controlled, and the latest information on vaccination to prevent varicella and zoster are presented and discussed.
The current status of live attenuated varicella vaccine (Gershon, A. A.); Evidence for frequent reactivation of the Oka varicella vaccine strain in healthy vaccines (Krause, P. R.); Investigation of varicella-zoster virus variation by heteroduplex mobility assay (Barrett-Muir, W., Hawrami, K., Clarke, J., Breuer, J.); Varicella-zoster virus with a lost gE epitope: evidence for immunological pressure by the human antibody response (Padilla, J. A., Grose, C.); Biologic and geographic differences between vaccine and clinical varicella-zoster virus isolates (LaRussa, P. S., Gershon, A. A.); Comparison of DNA sequence and transactivation activity of open reading frame 62 of Oka varicella vaccine and its parental viruses (Gomi, Y., Imagawa, T., Takahashi, M., Yamanishi, K.); Cis and trans elements regulating expression of the varicella-zoster virus gI gene (He, H., Boucaud, D., Hay, J., Ruyechan, W. T.); Interactions among structural proteins of varicella-zoster virus (Spengler, M., Niesen, N., Grose, C., Ruyechan, W. T., Hay, J.); The role of varicella-zoster virus immediate-early proteins in latency and their potential use as components of vaccines (Sadzot-Delvaux, C., Rentier, B.); Mutagenesis of the varicella-zoster virus genome: lessons learned (Cohen, J. I.); Immune evasion mechanisms of varicella-zoster virus (Abendroth, A., Arvin, A.); Pathway of viral spread in herpes zoster: detection of the protein encoded by open reading frame 63 of varicella-zoster virus in biopsy specimens (Iwasaki, T., Muraki, R., Kasahara, T., Sato, Y., Sata, T., Kurata, T.); Vaccination against cytomegalovirus (Plotkin, S. A.); Varicella-zoster virus in human and rat tissue specimens (Annunziato, P. W., Lungu, O., Panagiotidis, C.); In vitro measurement of human T cell responses to varicella-zoster virus antigen (Hayward, A. R.); Use of varicella vaccines to prevent herpes zoster in older individuals (Levin, M. J.); Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction (Takahashi, M., Kamiya, H., Asano, Y., Shiraki, K., Baba, K., Otsuka, T., Hirota, T., Yamanishi, K.); Varicella-zoster virus immunity and prevention: a conference perspective (Straus, S. E.).
| Erscheint lt. Verlag | 28.3.2001 |
|---|---|
| Zusatzinfo | 24 black & white illustrations |
| Verlagsort | Vienna |
| Sprache | englisch |
| Maße | 210 x 279 mm |
| Gewicht | 780 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Dermatologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Mikrobiologie / Infektologie / Reisemedizin | |
| ISBN-10 | 3-211-83556-3 / 3211835563 |
| ISBN-13 | 978-3-211-83556-2 / 9783211835562 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
